Johan Wedell-Wedellsborg, Director at Y-mAbs Therapeutics, Inc. (YMAB), bought 101,740 shares at $9.65 ($982K) on 2023-05-15, disclosed to the SEC on 2023-05-17.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| YMAB | BUY | 2023-12-01 | $619K | — | Filing → |
| YMAB | BUY | 2023-11-29 | $1.0M | — | Filing → |
| YMAB | SELL | 2021-06-11 | $812K | — | Filing → |